IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions
Hung, Chung-Lieh1,2,3; Hou, Charles Jia-Yin1,2,3; Hu, Gwo-Chi4; Kuo, Jen-Yuan2,5,6; Hsu, Chia-Yu4; Tsai, Cheng-Ho2; Yeh, Hung-I1,2; Bulwer, Bernard E.7,8; Hsieh, Ya-Ching9
关键词Aging Diabetes Heart Failure Hfpef Hypertension
刊名INTERNATIONAL JOURNAL OF GERONTOLOGY
2013-03-01
DOI10.1016/j.ijge.2013.01.009
7期:1页:1-7
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Geriatrics & Gerontology
研究领域[WOS]Geriatrics & Gerontology
关键词[WOS]VENTRICULAR SYSTOLIC FUNCTION ; QUALITY-OF-LIFE ; DIASTOLIC DYSFUNCTION ; LONG-TERM ; PULMONARY-HYPERTENSION ; MYOCARDIAL FIBROSIS ; CONSENSUS STATEMENT ; CLINICAL-FEATURES ; CARDIAC-FUNCTION ; ELDERLY-PATIENTS
英文摘要

Significant progress in our understanding of risk factors and interventions in heart failure, a leading cause of death and disability, has occurred in recent years. Several advances in therapy for heart failure with reduced left ventricular systolic function (i.e., systolic heart failure) have led to significantly improved outcomes. Treatment options for diastolic heart failure, also known as heart failure with preserved ejection fraction (HFpEF), by contrast, remain comparatively limited. In part, this is due to gaps in our understanding of the underlying pathophysiology and the lack of standardized criteria for its diagnosis and classification. Aging and hypertension remain the leading causes of HFpEF; increased ventricular and vascular stiffness is a feature of both. Comorbidities such as diabetes, renal insufficiency, and metabolic abnormalities further aggravate disease process, and data regarding effective treatment are lacking. This article discusses the risks, mechanisms, and outcomes of HFpEF from previous studies, and summarizes potential interventions that may provide new insights into our understanding of the disease and its treatment. Copyright (C) 2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.

语种英语
WOS记录号WOS:000317945800001
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56727
专题北京大学第一临床医学院
作者单位1.Mackay Med Coll, New Taipei City 252, New Taipei Coun, Taiwan
2.Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan
3.Mackay Med Nursing & Management Coll, Taipei, Taiwan
4.Mackay Mem Hosp, Dept Rehabil Med, Taipei, Taiwan
5.Vet Gen Hosp, Taipei, Taiwan
6.Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
7.Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
8.Natl Yang Ming Univ, Sch Med, Dept Med, Div Cardiol, Taipei 112, Taiwan
9.Peking Univ, Hosp 1, Dept Anesthesia, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Hung, Chung-Lieh,Hou, Charles Jia-Yin,Hu, Gwo-Chi,et al. Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions[J]. INTERNATIONAL JOURNAL OF GERONTOLOGY,2013,7(1):1-7.
APA Hung, Chung-Lieh.,Hou, Charles Jia-Yin.,Hu, Gwo-Chi.,Kuo, Jen-Yuan.,Hsu, Chia-Yu.,...&Hsieh, Ya-Ching.(2013).Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions.INTERNATIONAL JOURNAL OF GERONTOLOGY,7(1),1-7.
MLA Hung, Chung-Lieh,et al."Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions".INTERNATIONAL JOURNAL OF GERONTOLOGY 7.1(2013):1-7.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hung, Chung-Lieh]的文章
[Hou, Charles Jia-Yin]的文章
[Hu, Gwo-Chi]的文章
百度学术
百度学术中相似的文章
[Hung, Chung-Lieh]的文章
[Hou, Charles Jia-Yin]的文章
[Hu, Gwo-Chi]的文章
必应学术
必应学术中相似的文章
[Hung, Chung-Lieh]的文章
[Hou, Charles Jia-Yin]的文章
[Hu, Gwo-Chi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。